Lesion and Procedural Characteristics on Infrapopliteal Endovascular Procedures in Latin America: Insights from SOLACI Peripheral Registry - European Medical Journal

Continue

Lesion and Procedural Characteristics on Infrapopliteal Endovascular Procedures in Latin America: Insights from SOLACI Peripheral Registry

2 Mins
Interventional Cardiology
Authors:
*Virgen-Carrillo Luis Ramón,1 Lugo-Gavidia Leslie Marisol,2 Díaz Larry,3 Rossi Maximiliano,4 Pedernera Gustavo Omar,5 Duarte Ernesto Ramon,6 Pascua Julio Andrés,7 Lamelas Pablo8
  • 1. Virgen Cardiovascular Research, Universidad Autonóma de Guadalajara, Mexico
  • 2. Mexican Academic Consortium for Clinical Data Acquisition, Mexico
  • 3. Ascension Borgess Hospital, Kalamazoo, Michigan, USA
  • 4. Instituto Cardiovascular Rosario, Argentina
  • 5. ICBA Instituto Cardiovascular, Buenos Aires, Argentina
  • 6. Hospital Escuela de Agudos Dr Madariaga, Posadas, Argentina
  • 7. Hospital Italiano La Plata, Buenos Aires, Argentina
  • 8. Instituto de Cardiologia y Cirugia Cardiovascular Hospital Universitario Fundacion Favaloro, Buenos Aires, Argentina
*Correspondence to [email protected]
Disclosure:

The authors have declared no conflicts of interest.

Citation:
EMJ Int Cardiol. ;12[1]:26-28. https://doi.org/10.33590/emjintcardiol/XIVR8781.
Keywords:
Infrapopliteal, Latin America, peripheral artery disease.

Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.

BACKGROUND AND AIMS

Infrapopliteal lesions in patients with peripheral artery disease are becoming more common due to the global increase of risk factors such as diabetes, renal, and metabolic disease.1 Angioplasty has recently been shown to be superior to surgery for treating arterial disease below the knee.2 However, these patients commonly present multilevel disease, small calibre, and long lesions with high calcium burden, making endovascular interventions for the infrapopliteal region extremely challenging.1 A wide spectrum of revascularisation strategies and technologies have been developed to address the therapeutic needs  in the infrapopliteal space of this region, including support catheters, retrograde access, specialised balloons, and atherectomy for calcified vessels.1, 3-5 The use of stents in this region is currently under investigation. The recent LIFE-BTK study showed better efficacy for adverse limb outcomes with reabsorbable scaffolds placement compared to angioplasty.6 However, the trial included a highly selected population, and the use of stents in infrapopliteal lessions is still uncommon (and not widely available) in world-wide ‘real’ clinical practice.

The aim of this current study is to describe the lesion characteristics, and procedural and technical aspects of infrapopliteal endovascular procedures in Latin America.

MATERIALS AND METHODS

The cohort included patients derived from the Latin American Society of Interventional Cardiology (SOLACI) peripheral registry. SOLACI peripheral is a prospective, multi-centre, observational, and hospital-based registry of patients with lower-limb peripheral arterial disease, who were treated with endovascular interventions across 10 Latin American countries.7 A total of 1,120 procedures were included in the SOLACI peripheral registry between January 2017–May 2023. The current analysis focuses on infrapopliteal interventions, performed as part of a single or multilevel revascularisation strategies (N=554 procedures).

RESULTS

Overall, there was a high prevalence of cardiovascular risk factors and concomitant comorbidities, including hypertension (82.5%), dyslipidaemia (63.4%), diabetes (79.4%), myocardial infarction (15.7%), and stroke (9.0%). Most patients had chronic limb-threatening ischaemia (CLTI; 81.9%), while 17.7% presented with advanced intermittent claudication. From the entire cohort, 27 lesions had a previous endovascular treatment. More than one territory was treated in 250 procedures (45.1%). The target infrapopliteal lesions had a length of 144±88.4 mm and a diameter of 2.82±0.7 mm. Moderate calcification was present in 51.3% and 28.2% presented severe calcification. Atherectomy was used in 1.3%. Stenting was used in 8.5% (47 interventions), of which 22 (3.9%) were performed as rescue stenting or bail-out. Lesions treated with stents were wider (mean diameter 3.20±0.70 mm versus 2.79±0.70 mm) and shorter (mean length 111±101 mm versus 147.0±86.6 mm) compared to lesions treated with balloon angioplasty alone. Most of the procedures using stents required a single device, and only 10 patients required two or more stents. Coronary drug eluting stents were the most commonly used (74.4%). Successful revascularisation was achieved in 533 procedures (96.2%), with 19.1% of the procedures using indirect revascularization. The most frequent intraprocedural complication was thrombosis; 4.3% among patients with stents and 1.8% in patients without stents. Other main complications included embolism (1.3%), and access site haematoma (1.1%). Major adverse events during hospitalisation included death (1.8%), cardiovascular death (0.9%), myocardial infarction (0.5%), and stroke (0.2%).

CONCLUSION

This study illustrates the real-world Latin-American experience, and demonstrates the complexity of infrapopliteal procedures (high-risk factors, comorbidities burden, and complex lesions). Even though some procedures required specialised strategies (e.g., indirect revascularisation, retrograde access), there was a high rate of successful revascularisation with low use of additional dedicated devices such as atherectomy or stents. These strategies can help to reduce costs, amputations, and complications.

Figure 1: Lesion and Procedural Features of Infrapopliteal Endovascular Procedures from SOLACI Peripheral.
CABG: coronary artery bypass surgery; DES: drug-eluting stents; ICP: intracardiac microaxial pump; SOLACI: Latin American Society of Interventional Cardiology; TIA: transient ischaemic attack.

References
Beckman JA et al. Advances in revascularisation for peripheral artery disease: revascularisation in PAD. Circ Res. 2021;128(12):1885-912. Bradbury AW et al. A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion (BASIL-2): an open-label, randomised, multicentre, phase 3 trial. Lancet. 2023;401(10390):1798-809. Ambler GK et al. Atherectomy for peripheral arterial disease. Cochrane Database Syst Rev. 2014;17(3):CD006680. Schmidt A et al. Retrograde tibioperoneal access for complex infrainguinal occlusions: short- and long-term outcomes of 554 endovascular interventions. JACC Cardiovasc Interv. 2019;12(17):1714-26. Giannopoulos S et al. Three-year outcomes from the LIBERTY 360 study of endovascular interventions for peripheral artery disease stratified by Rutherford category. J Endovasc Ther. 2021;28(2):262-74. Varcoe RL et al. Drug-eluting resorbable scaffold versus angioplasty for infrapopliteal artery disease. N Engl J Med. 2024;390(1):9-19. Virgen-Carrillo LR et al. Rationale and design of the Latin-American registry of peripheral interventions: insights from SOLACI peripheral. JSCAI. 2024;DOI:10.1016/j.jscai.2024.101931.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.